Damora Therapeutics is trading at $20.61, down 5.04%, with no fresh company-specific announcement identified for October 23.
- The company’s investor-relations page lists an October 2 release as its latest news.
- Broader risk-off pressure may be contributing: the Dow is down 1.01%, while healthcare is up 1.35%.
- The available market quote reports a prior close of $21.71; the current price is from the supplied live price context.